Dr. Leon Bernal-Mizrachi, MD
- Medicare services, 2024
- 98
- Medicare patients, 2024
- 69
- Part D claims, 2024
- 702
- Publications
- 28
- Clinical trials
- 2
- Practice address
- 329 Nc Highway 801 N, Bermuda Run, NC 27006
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Davie Surgery - Ophthalmology - HOPD
Acute Care Hospital outpatient department · Bermuda Run, North Carolina
Find Dr. Bernal-Mizrachi's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Leon Bernal-Mizrachi is a hematologist and oncologist in Advance, North Carolina
Dr. Bernal-Mizrachi practices at Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina.
Dr. Bernal-Mizrachi's NPI, 1942336920, was assigned on February 26, 2007. Dr. Bernal-Mizrachi holds Georgia license 057283.
- NPI
- 1942336920NPI Registry (opens in a new tab)
- Medicare PAC ID
- 6901907781
- NPI enumeration date
- February 26, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 54
- Medical school graduation
- 1998
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Leon Bernal-Mizrachi practices at Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina
Dr. Bernal-Mizrachi's primary practice is Davie Surgery - Ophthalmology - HOPD, at 329 Nc Highway 801 N, Bermuda Run, NC 27006.
- Davie Surgery - Ophthalmology - HOPD329 Nc Highway 801 N, Bermuda Run, NC 27006
Source: Dmand AI Affiliation Data
Dr. Leon Bernal-Mizrachi is affiliated with 3 sites of care and 3 medical groups
Dr. Bernal-Mizrachi's primary practice is Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina. Dr. Bernal-Mizrachi is also affiliated with Atrium Health Wake Forest Baptist Medical Center. The medical group on file is Atrium Health Wake Forest Baptist. Dmand AI also links Dr. Bernal-Mizrachi to 1 more hospital and 2 medical groups, each named with a free account.
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Leon Bernal-Mizrachi's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bernal-Mizrachi practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Davie Surgery - Ophthalmology - HOPD | Available with a free account |
| +2 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Leon Bernal-Mizrachi is one of 420 hematologists and oncologists in North Carolina
Hematology and oncology is Dr. Bernal-Mizrachi's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Bernal-Mizrachi is licensed in Georgia.
Specialties and state licenses
- Hematology and oncology, GeorgiaPrimary
Hematologists and oncologists near Dr. Bernal-Mizrachi
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Leon Bernal-Mizrachi billed Medicare for 98 services in 2024
CMS data shows 98 Medicare services from Dr. Bernal-Mizrachi across 2 procedure codes in 2024, for 69 Medicare patients. Medicare paid $6,675 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Bernal-Mizrachi's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 372024: 98165%
Dr. Bernal-Mizrachi compared with the North Carolina median for hematologists and oncologists, 2024
- Dr. Bernal-Mizrachi
- North Carolina median
- Medicare services
- 98vs 45078% below
- Medicare patients
- 69vs 18062% below
- Part D claims
- 574vs 32477% above
Medians across 402 hematologists and oncologists in North Carolina with Dmand AI profiles that report each measure.
Dr. Bernal-Mizrachi's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Bernal-Mizrachi?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Bernal-Mizrachi and other hematologists and oncologists in North Carolina.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Leon Bernal-Mizrachi treated 69 Medicare patients in 2024, average age 68
CMS counts 69 Medicare patients who saw Dr. Bernal-Mizrachi in 2024. The largest group is 65 to 74, with 27 patients. 75% of them have high blood pressure, and 51% have high cholesterol. 58% are also on Medicaid. Their average risk score is 2.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Bernal-Mizrachi's median patient age at 69, with 43% women.
Dr. Bernal-Mizrachi's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Bernal-Mizrachi's Medicare patients by sex, 2024
- Women3855%
- Men3145%
Chronic conditions among Dr. Bernal-Mizrachi's Medicare patients, 2024
- High blood pressure75%
- High cholesterol51%
- Chronic kidney disease48%
- Arthritis46%
- Diabetes33%
- Heart failure33%
- Ischemic heart disease29%
- Anxiety20%
Share of Medicare patients with each condition. A patient can have several.
Dr. Bernal-Mizrachi's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 69
Patient panel by sex, all payers
- Women43%
- Men57%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Leon Bernal-Mizrachi wrote 702 Medicare Part D claims in 2024
In 2024, Dr. Bernal-Mizrachi wrote 702 Medicare Part D claims for 65 patients. 75% of them were for generic drugs. CMS names the drug for 574 of them, across 16 drugs with 11 or more claims each, at $2,820,261 in total drug cost. In 2023, CMS named 673 claims across 14 drugs.
Dr. Bernal-Mizrachi's Part D claims by kind of drug, 2024
- Generic529 claims75%
- Brand-name173 claims25%
Dr. Bernal-Mizrachi's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Bernal-Mizrachi's Part D claims, 2024
- Opioids10%72 of 702 claims
- Antibiotics3%19 of 702 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 6732024: 57415%
Drugs named by CMS: 16 in 2024, 14 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Leon Bernal-Mizrachi scored 95 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Bernal-Mizrachi for performance year 2024, reported through an alternative payment model (APM). Dr. Bernal-Mizrachi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Bernal-Mizrachi's MIPS scores, performance year 2024
- 95of 100Final score
- 80.6of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Leon Bernal-Mizrachi has 28 publications on record
Dmand AI links 28 papers to Dr. Bernal-Mizrachi, published from 2010 to 2024. 2015 was the busiest year, with 2. The most frequent topics are Lymphoma, Large B-Cell, Diffuse, Cell Line, Tumor and Antineoplastic Agents. Dr. Bernal-Mizrachi has published most often in Leuk Lymphoma. Dr. Bernal-Mizrachi's most frequent co-authors are Sagar Lonial, MD, Izidore Lossos, MD and Christopher Robert Flowers, MD.
Dr. Bernal-Mizrachi's papers by year, 2013 to 2024
Topics Dr. Bernal-Mizrachi writes about most
- Lymphoma, Large B-Cell, Diffuse
- Cell Line, Tumor
- Antineoplastic Agents
- Base Sequence
- Antineoplastic Combined Chemotherapy Protocols
- Molecular Sequence Data
- Multiple Myeloma
- Administration, Oral
Dr. Bernal-Mizrachi's most frequent co-authors
- Sagar Lonial, MD5 shared papers
- Izidore Lossos, MD5 shared papers
- Christopher Robert Flowers, MD4 shared papers
Recent publications by Dr. Bernal-Mizrachi
Blood Cancer J
See who Dr. Bernal-Mizrachi researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Bernal-Mizrachi works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Leon Bernal-Mizrachi has worked on 2 clinical trials
Dmand AI links Dr. Bernal-Mizrachi to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Deltaretrovirus Infections, Multiple Myeloma and Blood Protein Disorders.
Clinical trials with Dr. Bernal-Mizrachi by phase
- 1Phase 1: 1 trial
- NonePhase 2: no trials
- NonePhase 3: no trials
- 1Phase 4: 1 trial
Conditions in Dr. Bernal-Mizrachi's trials
- Deltaretrovirus Infections
- Multiple Myeloma
- Blood Protein Disorders
- HTLV-I Infections
Investigators on the most trials with Dr. Bernal-Mizrachi
- Murtaza N. Bhuriwala, MD1 shared trial
- Ruemu E. Birhiray, MD1 shared trial
- Sultan Aleem Chowdhary, MD1 shared trial
Recent clinical trials with Dr. Bernal-Mizrachi
A Phase 1 Study of Lenalidomide in Combination With EPOCH Chemotherapy for HTLV-Associated Adult T-Cell Leukemia-Lymphoma (ATLL) (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Leon Bernal-Mizrachi received $94,415 in industry payments from 2016 to 2025
CMS Open Payments shows 86 general payments to Dr. Bernal-Mizrachi from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 58% of the total. Celgene Corporation paid the most, $36,677.
General payments to Dr. Bernal-Mizrachi by program year, 2016 to 2025
General payments to Dr. Bernal-Mizrachi by kind, 2016 to 2025
- Consulting fees$54,30258%
- Speaker and faculty fees$27,00029%
- Travel and lodging$11,13012%
- Food and beverage$1,6832%
- Education$3000%
Companies that paid Dr. Bernal-Mizrachi the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Leon Bernal-Mizrachi's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Leon Bernal-Mizrachi
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Leon Bernal-Mizrachi's NPI number?
Dr. Leon Bernal-Mizrachi's NPI number is 1942336920. It was assigned on February 26, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Leon Bernal-Mizrachi?
Dr. Leon Bernal-Mizrachi is a hematologist and oncologist in Advance, North Carolina. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Leon Bernal-Mizrachi practice?
Dr. Bernal-Mizrachi practices at 329 Nc Highway 801 N, Bermuda Run, NC 27006. Dr. Bernal-Mizrachi's primary practice is Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina. Dmand AI also links Dr. Bernal-Mizrachi to 1 hospital and 2 medical groups.
What is Dr. Leon Bernal-Mizrachi's medical license number?
Dr. Bernal-Mizrachi holds Georgia license 057283.
Which hospitals is Dr. Leon Bernal-Mizrachi affiliated with?
Dr. Bernal-Mizrachi is affiliated with Atrium Health Wake Forest Baptist Medical Center. Dmand AI links Dr. Bernal-Mizrachi to 1 more hospital.
What medical group is Dr. Leon Bernal-Mizrachi part of?
Dr. Bernal-Mizrachi is linked to Atrium Health Wake Forest Baptist. Dmand AI links Dr. Bernal-Mizrachi to 2 more medical groups.
Does Dr. Leon Bernal-Mizrachi accept Medicare?
Yes. CMS data shows Dr. Bernal-Mizrachi billed Medicare for 98 services in 2024, and Dr. Bernal-Mizrachi accepts Medicare assignment.
What is Dr. Leon Bernal-Mizrachi's MIPS score?
Dr. Bernal-Mizrachi's MIPS final score for performance year 2024 is 95 out of 100, reported through an alternative payment model (APM).
How many Medicare patients does Dr. Leon Bernal-Mizrachi see?
CMS counts 69 Medicare patients who saw Dr. Bernal-Mizrachi in 2024, with an average age of 68.
What services does Dr. Leon Bernal-Mizrachi bill to Medicare?
In 2024, Dr. Bernal-Mizrachi's most billed Medicare services were office visit, established patient (99214) and hospital inpatient care (99232).
Show 5 more questionsShow fewer questions
What drugs does Dr. Leon Bernal-Mizrachi prescribe most?
In 2024 Medicare Part D data, Dr. Bernal-Mizrachi's most prescribed drugs by claims were Acyclovir, Dexamethasone and Lenalidomide.
Has Dr. Leon Bernal-Mizrachi received payments from drug or device companies?
CMS Open Payments shows $94,415 in general payments to Dr. Bernal-Mizrachi from 9 companies from 2016 to 2025. The largest total came from Celgene Corporation.
How long has Dr. Leon Bernal-Mizrachi been practicing?
Dr. Bernal-Mizrachi graduated from medical school in 1998, 28 years ago.
Does Dr. Leon Bernal-Mizrachi do research?
Dmand AI links 28 publications to Dr. Bernal-Mizrachi, published from 2010 to 2024. Dr. Bernal-Mizrachi has worked on 2 clinical trials.
Who does Dr. Leon Bernal-Mizrachi publish with?
Dr. Bernal-Mizrachi's most frequent co-authors are Sagar Lonial, MD (5 shared papers), Izidore Lossos, MD (5 shared papers) and Christopher Robert Flowers, MD (4 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in North Carolina by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card